Webinar by Bioteck Scientific department about the technical and clinical features of Bioteck products
Do you know how Bioteck products are manufactured? How Bioteck products interact with the biological components of the patient? Why Bioteck products are completely remodeled with patient’s bone in physiological time?
To provide doctors with the answer to these, and also answer your questions, Bioteck Academy in collaboration with Implant Support Services has organized 2 webinars. The first webinar will take place on 27 July 2021 an be held by the Bioteck Scientific Department. It will focus on the technical and clinical features of Bioteck bone substitutes, membranes and three-dimensional matrices.
1st Session: Technological Webinar
Tuesday 27 July 2021
19:00 – 21:00 UTC +2 Time
All you want to know about the technical and clinical features of the ultimate heterologous tissues for bone regeneration: Bioteck medical devices.
View the recorded webinar:
- The Zymo-Teck process: how to transform the heterologous tissues in the best alternative to human tissues
- Bioteck Bone substitutes:
• OSTEOXENON collagenic bone substitutes: complete remodeling for the most favorable biological environment around implants
- Bioteck membranes:
• HEART pericardium membrane: protection and mechanical resistance for all kind of bone regenerative surgery
- Bioteck 3D matrices:
• XC COLLAGEN Xenomatrix : the scaffold for soft tissue regeneration
- Q&A session
Bioteck and its scientific staff
Bioteck® is an Italian company founded in 1995, a leader in the production and development of bone and tissue substitutes for regenerative surgery in orthopedics, neurosurgery and oralmaxillofacial surgery. Bioteck® turned 25 years old, an important milestone that has its roots in Zymo-Teck®, the exclusive enzymatic deantigenation process of heterologous tissues that has redefined the quality standards of bone grafts and membranes of biological origin. Proud of the unique features of its biomaterials and of their clinical efficacy, Bioteck® promotes the sharing of clinical/scientific knowledge about regenerative medicine and its medical devices through the Bioteck Academy.
Dr. Marco Morroni
Dr. Marco Morroni is the Scientific and Regulatory Affairs Director of Bioteck. After a Research Master’s Degree in Biotechnology at the University of Milan, he earned a PhD in the field of Biological and Molecular Sciences at the International Center for Genetic Engineering and Biotechnology (ICGEB}, where he carried out research in the field of biosafety of Genetically Modified Organisms. Co-author of 6 international publications and of a host of scientific/educational articles, he lectured at a number of national and international conferences both in Italy and abroad. For some years now he has dealt with tissue regeneration in cooperation with the Universities of Padua, Brescia, San Raffaele Vita e Salute (Milan}, Florence.
Dr. Matteo Colombo
Dr. Matteo Colombo is the Scientific and Communication Specialist of Bioteck since 2019. Graduated in Medical Biotechnology in 2008 at the University of Milano-Bicocca, he obtained his PhD in Cellular and Molecular Biology at the University of Milan. He continued his research activity in Grenoble, France at the Institute de Biologie Structurale and at the European Molecular Biology Laboratory where he investigated the three-dimensional structure of enzymes involved in peptides degradation and cellular differentiation.He is co-author of 13 scientific publications, and he participated as speaker in various conferences in Italy and abroad.